Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.56 |
| ▸ | PRKCI | P41743 | 1/20 | 0.56 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.51 |
| ▸ | FYN | P06241 | 4/20 | 0.50 |
| ▸ | CBFB | Q13951 | 1/20 | 0.49 |
| ▸ | KDM1A | O60341 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
| ▸ | CDK8 | P49336 | 1/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | CTSL | P07711 | 1/20 | 0.45 |
| ▸ | CTSB | P07858 | 1/20 | 0.45 |
| ▸ | CTSS | P25774 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | CCR1 | P32246 | 1/20 | 0.45 |
| ▸ | CCR5 | P51681 | 1/20 | 0.45 |
| ▸ | CCR8 | P51685 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1139044 | 0.86 | HRH3 (0.57) | HRH3PRKCIFFAR1CDK8CYP2A6 | |
| SCHEMBL1733171 | 0.85 | HRH3 (0.52) | HRH3PRKCIFFAR1CYP2A6CTSL | |
| SCHEMBL16595254 | 0.83 | HRH3 (0.51) | HRH3FFAR1CDK8CYP2A6CTSL | |
| SCHEMBL4163504 | 0.82 | HRH3 (0.56) | HRH3FFAR1CYP2A6CTSLCTSB | |
| SCHEMBL29793738 | 0.82 | HRH3 (0.56) | HRH3FFAR1CDK8CYP2A6KDM4E | |
| SCHEMBL2696099 | 0.82 | HRH3 (0.56) | HRH3FFAR1CDK8CYP2A6KDM4E | |
| SCHEMBL7392910 | 0.82 | HRH3 (0.56) | HRH3FFAR1CYP2A6CTSLCTSB | |
| SCHEMBL3953179 | 0.82 | HRH3 (0.56) | HRH3FFAR1CYP2A6CTSLCTSB | |
| SCHEMBL1129413 | 0.82 | HRH3 (0.56) | HRH3FFAR1CBFBCYP2A6CTSL | |
| SCHEMBL13537177 | 0.82 | HRH3 (0.56) | HRH3FFAR1CYP2A6CTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12442787-B2 | Transition metal electron transfer complex having C—N ligand and electrochemical bio sensor using same | I-SENS, INC. (KR) | 2025-10-14 | — | — | US | disclosed |
| CN-114867732-B | Novel transition metal electron transport complex having C-N ligand and electrochemical biosensor using the same | 爱-森新株式会社 | 2024-11-29 | — | — | CN | disclosed |
| US-20230125122-A1 | NOVEL TRANSITION METAL ELECTRON TRANSFER COMPLEX HAVING C-N LIGAND AND ELECTROCHEMICAL BIO SENSOR USING SAME | SOGANG UNIVERSITY RESEARCH & BUSINESS DEVELOPMENT FOUNDATION (KR) | 2023-04-27 | — | — | US | disclosed |
| US-20230125122-A1 | NOVEL TRANSITION METAL ELECTRON TRANSFER COMPLEX HAVING C-N LIGAND AND ELECTROCHEMICAL BIO SENSOR USING SAME | SOGANG UNIVERSITY RESEARCH & BUSINESS DEVELOPMENT FOUNDATION (KR) | 2023-04-27 | — | — | US | disclosed |
| US-20230125122-A1 | NOVEL TRANSITION METAL ELECTRON TRANSFER COMPLEX HAVING C-N LIGAND AND ELECTROCHEMICAL BIO SENSOR USING SAME | SOGANG UNIVERSITY RESEARCH & BUSINESS DEVELOPMENT FOUNDATION (KR) | 2023-04-27 | — | — | US | disclosed |
| EP-4079740-A1 | NOVEL TRANSITION METAL ELECTRON TRANSFER COMPLEX HAVING C-N LIGAND AND ELECTROCHEMICAL BIO SENSOR USING SAME | I-SENS, INC. (KR) | 2022-10-26 | — | — | EP | disclosed |
| EP-4079740-A1 | NOVEL TRANSITION METAL ELECTRON TRANSFER COMPLEX HAVING C-N LIGAND AND ELECTROCHEMICAL BIO SENSOR USING SAME | I-SENS, INC. (KR) | 2022-10-26 | — | — | EP | disclosed |
| CN-114867732-A | Novel transition metal electron transport complex having C-N ligand and electrochemical biosensor using the same | 爱-森新株式会社 | 2022-08-05 | — | — | CN | disclosed |
| WO-2021125791-A1 | NOVEL TRANSITION METAL ELECTRON TRANSFER COMPLEX HAVING C-N LIGAND AND ELECTROCHEMICAL BIO SENSOR USING SAME | 주식회사 아이센스 | 2021-06-24 | — | — | WO | disclosed |
| WO-2021125791-A1 | NOVEL TRANSITION METAL ELECTRON TRANSFER COMPLEX HAVING C-N LIGAND AND ELECTROCHEMICAL BIO SENSOR USING SAME | 주식회사 아이센스 | 2021-06-24 | — | — | WO | disclosed |
| US-6989383-B1 | Method of treating cancer | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2006-01-24 | — | — | US | disclosed |
| US-20050137207-A1 | Method of treating cancer | ROSEN NEAL (US) | 2005-06-23 | — | — | US | disclosed |
| EP-0973396-A4 | A METHOD OF TREATING CANCER | MERCK & CO INC (US) | 2001-02-07 | — | — | EP | disclosed |
| US-6060038-A | Radiolabeled farnesyl-protein transferase inhibitors | MERCK & CO., INC. (US) | 2000-05-09 | — | — | US | disclosed |
| EP-0986302-A1 | A METHOD OF TREATING CANCER | Merck & Co., Inc. (US) | 2000-03-22 | — | — | EP | disclosed |
| EP-0981728-A2 | RADIOLABELED FARNESYL-PROTEIN TRANSFERASE INHIBITORS | Merck & Co., Inc. (US) | 2000-03-01 | — | — | EP | disclosed |
| EP-0973396-A1 | A METHOD OF TREATING CANCER | Merck & Co., Inc. (US) | 2000-01-26 | — | — | EP | disclosed |
| WO-1999000654-A2 | RADIOLABELED FARNESYL-PROTEIN TRANSFERASE INHIBITORS | MERCK & CO., INC. (US) | 1999-01-07 | — | — | WO | disclosed |
| WO-1998054966-A1 | A METHOD OF TREATING CANCER | MERCK & CO., INC. (US) | 1998-12-10 | — | — | WO | disclosed |
| WO-1998044797-A1 | A METHOD OF TREATING CANCER | MERCK & CO., INC. (US) | 1998-10-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230125122-A1 | NOVEL TRANSITION METAL ELECTRON TRANSFER COMPLEX HAVING C-N LIGAND AND ELECTROCHEMICAL BIO SENSOR USING SAME | MB, CACYBP, SPR | HRH3 4644/4885PRKCI 3155/4885FFAR1 4639/4885 |
| US-12442787-B2 | Transition metal electron transfer complex having C—N ligand and electrochemical bio sensor using same | MB, CACYBP, SPR | HRH3 4573/4885PRKCI 3100/4885FFAR1 4658/4885 |
| US-20050137207-A1 | Method of treating cancer | FNTA, GGT1, NTPCR | HRH3 4538/4885PRKCI 967/4885FFAR1 4864/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.